Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · CHIEF EXECUTIVE OFFICER | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 806,111 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Tax withholding · Disposed 5,361 · Balance 806,111 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1 |
Reported balance
Holding disclosure · report date 2026-09-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1 F2: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
F2: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2022 Filed Mar 5, 2022 02:33 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,202 | $44.19 | $141,496.38 |
DisclosureSEC source: 0001104659-22-030782 · tm228503-1_4seq1.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 52,992 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.40, inclusive. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 02:33 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,200 | $43.49 | $95,678.00 |
DisclosureSEC source: 0001104659-22-030782 · tm228503-1_4seq1.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 56,194 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.12 to $43.98 inclusive. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 02:33 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,606 | $42.74 | $196,860.44 |
DisclosureSEC source: 0001104659-22-030782 · tm228503-1_4seq1.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 58,394 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.41 to $42.99, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:49 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 7,200 | $43.15 | $310,680.00 |
DisclosureSEC source: 0001179110-22-001971 · edgar.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 23,135 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.60, inclusive. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:49 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 10,400 | $42.47 | $441,688.00 |
DisclosureSEC source: 0001179110-22-001971 · edgar.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 30,335 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.97, inclusive. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:49 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,400 | $41.75 | $100,200.00 |
DisclosureSEC source: 0001179110-22-001971 · edgar.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 40,735 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.13 to $41.99, inclusive. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:49 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 500 | $40.52 | $20,260.00 |
DisclosureSEC source: 0001179110-22-001971 · edgar.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 43,135 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.01 to $40.93, inclusive. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:49 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 500 | $39.27 | $19,635.00 |
DisclosureSEC source: 0001179110-22-001971 · edgar.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 43,635 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.96 to $39.60, inclusive. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:49 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 125,931 | $39.09 | $4,922,642.79 |
DisclosureSEC source: 0001179110-22-001971 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 44,135 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.99 to $39.55, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 02:34 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,500 | $41.01 | $102,525.00 |
DisclosureSEC source: 0001179110-22-001412 · edgar.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 170,066 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F4 · price: The reportable securties are held directly by the PECO ANEVSKI 2020 SD LLC. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.02, inclusive. F4 · balance_after: The reportable securties are held directly by the PECO ANEVSKI 2020 SD LLC. F4 · ownership.nature: The reportable securties are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| February 15, 2022 Filed Feb 18, 2022 02:34 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 17,569 | $41.39 | $727,180.91 |
DisclosureSEC source: 0001179110-22-001412 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 172,566 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.33 to $41.55, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (5). F4 · ownership.nature: The reportable securties are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 01:58 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 600 | $42.00 | $25,200.00 |
DisclosureSEC source: 0001179110-22-001298 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 654,462 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.0050, inclusive. F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2). F4 · balance_after: Includes 445 common shares acquired under the Issuer's employee stock purchase plan. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| February 11, 2022 Filed Mar 2, 2022 23:20 UTC Amendment | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 600 | $42.00 | $25,200.00 |
DisclosureSEC source: 0001179110-22-001966 · edgar.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 190,135 F3 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.005, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. F2 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| January 25, 2022 Filed Mar 2, 2022 23:20 UTC Amendment | Progyny, Inc. PGNY · Entity 4521 | GiftCommon Stock | 128,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001966 · edgar.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 190,735 F2 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| January 25, 2022 Filed Mar 2, 2022 23:20 UTC Amendment | Progyny, Inc. PGNY · Entity 4521 | GiftCommon Stock | 128,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001966 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 526,927 F1 · balance_after: Includes 445 common shares acquired under the Issuer's employee stock purchase plan. Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 23:19 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 400 | $51.06 | $20,424.00 |
DisclosureSEC source: 0001179110-22-000280 · edgar.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 62,600 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F4 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (5). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.91 to $51.225, inclusive. F1 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:19 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 21,000 | $51.17 | $1,074,570.00 |
DisclosureSEC source: 0001179110-22-000280 · edgar.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 63,000 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.93 to $51.62, inclusive. F4 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (5). F1 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:19 UTC | Progyny, Inc. PGNY · Entity 4521 | GiftCommon Stock | 84,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000280 · edgar.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 84,000 F1 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:19 UTC | Progyny, Inc. PGNY · Entity 4521 | GiftCommon Stock | 84,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000280 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 654,617 Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 23:23 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantEmployee Stock Option (Right to Buy) · Derivative | 1,000,000 | $0.00 Strike: $50.35 | $0.00 |
DisclosureSEC source: 0001179110-22-000020 · edgar.xml · derivative · entry 2 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2031-12-31 F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option will vest January 1, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through January 1, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 23:23 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000020 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 738,617 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs will vest on January 1, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through January 1, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 07, 2021 Filed Oct 8, 2021 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 27,539 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009303 · edgar.xml · derivative · entry 8 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,107 Underlying: Common Stock · 27,539 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 07, 2021 Filed Oct 8, 2021 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 6,778 | $60.20 | $408,026.11 |
DisclosureSEC source: 0001179110-21-009303 · edgar.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,617 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021 F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.04 to $60.48, inclusive. Read SEC document |
| October 07, 2021 Filed Oct 8, 2021 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 15,981 | $59.46 | $950,222.27 |
DisclosureSEC source: 0001179110-21-009303 · edgar.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,395 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021 F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.99, inclusive. Read SEC document |
| October 07, 2021 Filed Oct 8, 2021 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,780 | $58.84 | $281,242.29 |
DisclosureSEC source: 0001179110-21-009303 · edgar.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,376 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021 F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.14 to $58.99, inclusive. Read SEC document |
| October 07, 2021 Filed Oct 8, 2021 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 27,539 | $0.91 | $25,060.49 |
DisclosureSEC source: 0001179110-21-009303 · edgar.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 06, 2021 Filed Oct 8, 2021 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,379 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009303 · edgar.xml · derivative · entry 7 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,646 Underlying: Common Stock · 12,379 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 06, 2021 Filed Oct 8, 2021 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 12,379 | $57.72 | $714,527.02 |
DisclosureSEC source: 0001179110-21-009303 · edgar.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,617 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.710 to $57.765, inclusive. F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). Read SEC document |
| October 06, 2021 Filed Oct 8, 2021 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 12,379 | $0.91 | $11,264.89 |
DisclosureSEC source: 0001179110-21-009303 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 23:32 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 27,500 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009233 · edgar.xml · derivative · entry 12 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 512,025 Underlying: Common Stock · 27,500 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 23:32 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 11,719 | $58.25 | $682,631.75 |
DisclosureSEC source: 0001179110-21-009233 · edgar.xml · nonDerivative · entry 9 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,617 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.77, inclusive. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 23:32 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 15,781 | $57.78 | $911,767.79 |
DisclosureSEC source: 0001179110-21-009233 · edgar.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,336 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.40 to $57.99, inclusive. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 23:32 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 27,500 | $0.91 | $25,025.00 |
DisclosureSEC source: 0001179110-21-009233 · edgar.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 23:32 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 27,500 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009233 · edgar.xml · derivative · entry 11 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,525 Underlying: Common Stock · 27,500 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 23:32 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 100 | $58.03 | $5,803.00 |
DisclosureSEC source: 0001179110-21-009233 · edgar.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,617 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 23:32 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 27,400 | $57.33 | $1,570,713.22 |
DisclosureSEC source: 0001179110-21-009233 · edgar.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,717 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.02 to $57.79, inclusive. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 23:32 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 27,500 | $0.91 | $25,025.00 |
DisclosureSEC source: 0001179110-21-009233 · edgar.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 23:32 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 27,500 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009233 · edgar.xml · derivative · entry 10 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567,025 Underlying: Common Stock · 27,500 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 23:32 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 20,100 | $57.42 | $1,154,121.90 |
DisclosureSEC source: 0001179110-21-009233 · edgar.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,617 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.000 to $57.905, inclusive. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 23:32 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 7,400 | $56.83 | $420,567.16 |
DisclosureSEC source: 0001179110-21-009233 · edgar.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 508,717 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.64 to $56.98, inclusive. F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 23:32 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 27,500 | $0.91 | $25,025.00 |
DisclosureSEC source: 0001179110-21-009233 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:41 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 88,882 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009044 · edgar.xml · derivative · entry 8 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594,525 Underlying: Common Stock · 88,882 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:41 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 21,800 | $57.16 | $1,246,157.76 |
DisclosureSEC source: 0001179110-21-009044 · edgar.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,617 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.41, inclusive. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:41 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 67,082 | $56.57 | $3,794,962.90 |
DisclosureSEC source: 0001179110-21-009044 · edgar.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,417 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.25 to $56.99, inclusive. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:41 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 88,882 | $0.91 | $80,882.62 |
DisclosureSEC source: 0001179110-21-009044 · edgar.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 577,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 20:41 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,700 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009044 · edgar.xml · derivative · entry 7 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683,407 Underlying: Common Stock · 8,700 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 20:41 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,500 | $56.27 | $140,675.00 |
DisclosureSEC source: 0001179110-21-009044 · edgar.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,617 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.27, inclusive. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 20:41 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 6,200 | $55.90 | $346,585.58 |
DisclosureSEC source: 0001179110-21-009044 · edgar.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,117 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.86 to $55.99, inclusive. F3 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 20:41 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 8,700 | $0.91 | $7,917.00 |
DisclosureSEC source: 0001179110-21-009044 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 21:04 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 55,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-008997 · edgar.xml · derivative · entry 14 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 692,107 Underlying: Common Stock · 55,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.